Noninvasive approach to indicate risk factors of nonalcoholic steatohepatitis overlapping autoimmune hepatitis based on peripheral lymphocyte pattern

Background Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA) positivity and overlap of autoimmune hepatitis (AIH). Discriminating AIH-overlap NASH from NAFLD/NASH is required for proper treatment,...

Full description

Saved in:
Bibliographic Details
Published inJournal of gastroenterology Vol. 58; no. 12; pp. 1237 - 1251
Main Authors Kado, Akira, Tsutsumi, Takeya, Yotsuyanagi, Hiroshi, Ikeuchi, Kazuhiko, Okushin, Kazuya, Moriya, Kyoji, Koike, Kazuhiko, Fujishiro, Mitsuhiro
Format Journal Article
LanguageEnglish
Published Singapore Springer Nature Singapore 01.12.2023
Springer
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA) positivity and overlap of autoimmune hepatitis (AIH). Discriminating AIH-overlap NASH from NAFLD/NASH is required for proper treatment, and typically involves pathological diagnosis by invasive liver biopsy. Differential patterns of peripheral lymphocytes in NAFLD and AIH were assessed to noninvasively indicate risk factors of AIH-overlap NASH by flow cytometry (FCM). Methods We assessed the differential frequencies of peripheral lymphocytes in 115 patients: 70 NASH (ANA negative:positive:AIH-overlap = 36:20:14), 18 NAFL, and 27 AIH (acute:chronic = 12:15) patients diagnosed by FCM. We focused on the following populations of lymphocytes: T cells, B cells, natural killer (NK) cells, NKT cells, helper T cell (Th) subsets (Th1, Th2, and Th17), and regulatory T cells; we also examined programmed cell death (PD) 1 and cytotoxic T-lymphocyte antigen levels. Results Several significant differences in laboratory parameters and peripheral lymphocyte frequencies were found among the NAFLD and AIH subgroups. In univariate and multivariate analyses, hyaluronic acid level, liver stiffness, and the frequencies of Th17 and CD8 + PD1 + T cells were independent risk factors of NASH in NAFLD. Regarding overlap of AIH, only the frequency of CD8 + PD1 + T cells (odds ratio, 0.01; 95% CI 0.00–38.9, p  = 0.004) was an independent risk factor in NASH and significantly decreased in AIH. Conclusions The decreased frequency of peripheral CD8 + PD1 + T cells is an independent risk factor of NASH overlapping with AIH in the present cohort. Our findings will facilitate development of a new noninvasive FCM method for indicating risk factors of NASH, including autoimmunity.
AbstractList Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA) positivity and overlap of autoimmune hepatitis (AIH). Discriminating AIH-overlap NASH from NAFLD/NASH is required for proper treatment, and typically involves pathological diagnosis by invasive liver biopsy. Differential patterns of peripheral lymphocytes in NAFLD and AIH were assessed to noninvasively indicate risk factors of AIH-overlap NASH by flow cytometry (FCM). We assessed the differential frequencies of peripheral lymphocytes in 115 patients: 70 NASH (ANA negative:positive:AIH-overlap = 36:20:14), 18 NAFL, and 27 AIH (acute:chronic = 12:15) patients diagnosed by FCM. We focused on the following populations of lymphocytes: T cells, B cells, natural killer (NK) cells, NKT cells, helper T cell (Th) subsets (Th1, Th2, and Th17), and regulatory T cells; we also examined programmed cell death (PD) 1 and cytotoxic T-lymphocyte antigen levels. Several significant differences in laboratory parameters and peripheral lymphocyte frequencies were found among the NAFLD and AIH subgroups. In univariate and multivariate analyses, hyaluronic acid level, liver stiffness, and the frequencies of Th17 and CD8 PD1 T cells were independent risk factors of NASH in NAFLD. Regarding overlap of AIH, only the frequency of CD8 PD1 T cells (odds ratio, 0.01; 95% CI 0.00-38.9, p = 0.004) was an independent risk factor in NASH and significantly decreased in AIH. The decreased frequency of peripheral CD8 PD1 T cells is an independent risk factor of NASH overlapping with AIH in the present cohort. Our findings will facilitate development of a new noninvasive FCM method for indicating risk factors of NASH, including autoimmunity.
Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA) positivity and overlap of autoimmune hepatitis (AIH). Discriminating AIH-overlap NASH from NAFLD/NASH is required for proper treatment, and typically involves pathological diagnosis by invasive liver biopsy. Differential patterns of peripheral lymphocytes in NAFLD and AIH were assessed to noninvasively indicate risk factors of AIH-overlap NASH by flow cytometry (FCM). We assessed the differential frequencies of peripheral lymphocytes in 115 patients: 70 NASH (ANA negative:positive:AIH-overlap = 36:20:14), 18 NAFL, and 27 AIH (acute:chronic = 12:15) patients diagnosed by FCM. We focused on the following populations of lymphocytes: T cells, B cells, natural killer (NK) cells, NKT cells, helper T cell (Th) subsets (Th1, Th2, and Th17), and regulatory T cells; we also examined programmed cell death (PD) 1 and cytotoxic T-lymphocyte antigen levels. Several significant differences in laboratory parameters and peripheral lymphocyte frequencies were found among the NAFLD and AIH subgroups. In univariate and multivariate analyses, hyaluronic acid level, liver stiffness, and the frequencies of Th17 and CD8.sup.+ PD1.sup.+ T cells were independent risk factors of NASH in NAFLD. Regarding overlap of AIH, only the frequency of CD8.sup.+ PD1.sup.+ T cells (odds ratio, 0.01; 95% CI 0.00-38.9, p = 0.004) was an independent risk factor in NASH and significantly decreased in AIH. The decreased frequency of peripheral CD8.sup.+ PD1.sup.+ T cells is an independent risk factor of NASH overlapping with AIH in the present cohort. Our findings will facilitate development of a new noninvasive FCM method for indicating risk factors of NASH, including autoimmunity.
Background Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA) positivity and overlap of autoimmune hepatitis (AIH). Discriminating AIH-overlap NASH from NAFLD/NASH is required for proper treatment, and typically involves pathological diagnosis by invasive liver biopsy. Differential patterns of peripheral lymphocytes in NAFLD and AIH were assessed to noninvasively indicate risk factors of AIH-overlap NASH by flow cytometry (FCM). Methods We assessed the differential frequencies of peripheral lymphocytes in 115 patients: 70 NASH (ANA negative:positive:AIH-overlap = 36:20:14), 18 NAFL, and 27 AIH (acute:chronic = 12:15) patients diagnosed by FCM. We focused on the following populations of lymphocytes: T cells, B cells, natural killer (NK) cells, NKT cells, helper T cell (Th) subsets (Th1, Th2, and Th17), and regulatory T cells; we also examined programmed cell death (PD) 1 and cytotoxic T-lymphocyte antigen levels. Results Several significant differences in laboratory parameters and peripheral lymphocyte frequencies were found among the NAFLD and AIH subgroups. In univariate and multivariate analyses, hyaluronic acid level, liver stiffness, and the frequencies of Th17 and CD8.sup.+ PD1.sup.+ T cells were independent risk factors of NASH in NAFLD. Regarding overlap of AIH, only the frequency of CD8.sup.+ PD1.sup.+ T cells (odds ratio, 0.01; 95% CI 0.00-38.9, p = 0.004) was an independent risk factor in NASH and significantly decreased in AIH. Conclusions The decreased frequency of peripheral CD8.sup.+ PD1.sup.+ T cells is an independent risk factor of NASH overlapping with AIH in the present cohort. Our findings will facilitate development of a new noninvasive FCM method for indicating risk factors of NASH, including autoimmunity.
Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA) positivity and overlap of autoimmune hepatitis (AIH). Discriminating AIH-overlap NASH from NAFLD/NASH is required for proper treatment, and typically involves pathological diagnosis by invasive liver biopsy. Differential patterns of peripheral lymphocytes in NAFLD and AIH were assessed to noninvasively indicate risk factors of AIH-overlap NASH by flow cytometry (FCM).BACKGROUNDNonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA) positivity and overlap of autoimmune hepatitis (AIH). Discriminating AIH-overlap NASH from NAFLD/NASH is required for proper treatment, and typically involves pathological diagnosis by invasive liver biopsy. Differential patterns of peripheral lymphocytes in NAFLD and AIH were assessed to noninvasively indicate risk factors of AIH-overlap NASH by flow cytometry (FCM).We assessed the differential frequencies of peripheral lymphocytes in 115 patients: 70 NASH (ANA negative:positive:AIH-overlap = 36:20:14), 18 NAFL, and 27 AIH (acute:chronic = 12:15) patients diagnosed by FCM. We focused on the following populations of lymphocytes: T cells, B cells, natural killer (NK) cells, NKT cells, helper T cell (Th) subsets (Th1, Th2, and Th17), and regulatory T cells; we also examined programmed cell death (PD) 1 and cytotoxic T-lymphocyte antigen levels.METHODSWe assessed the differential frequencies of peripheral lymphocytes in 115 patients: 70 NASH (ANA negative:positive:AIH-overlap = 36:20:14), 18 NAFL, and 27 AIH (acute:chronic = 12:15) patients diagnosed by FCM. We focused on the following populations of lymphocytes: T cells, B cells, natural killer (NK) cells, NKT cells, helper T cell (Th) subsets (Th1, Th2, and Th17), and regulatory T cells; we also examined programmed cell death (PD) 1 and cytotoxic T-lymphocyte antigen levels.Several significant differences in laboratory parameters and peripheral lymphocyte frequencies were found among the NAFLD and AIH subgroups. In univariate and multivariate analyses, hyaluronic acid level, liver stiffness, and the frequencies of Th17 and CD8+ PD1+ T cells were independent risk factors of NASH in NAFLD. Regarding overlap of AIH, only the frequency of CD8+ PD1+ T cells (odds ratio, 0.01; 95% CI 0.00-38.9, p = 0.004) was an independent risk factor in NASH and significantly decreased in AIH.RESULTSSeveral significant differences in laboratory parameters and peripheral lymphocyte frequencies were found among the NAFLD and AIH subgroups. In univariate and multivariate analyses, hyaluronic acid level, liver stiffness, and the frequencies of Th17 and CD8+ PD1+ T cells were independent risk factors of NASH in NAFLD. Regarding overlap of AIH, only the frequency of CD8+ PD1+ T cells (odds ratio, 0.01; 95% CI 0.00-38.9, p = 0.004) was an independent risk factor in NASH and significantly decreased in AIH.The decreased frequency of peripheral CD8+ PD1+ T cells is an independent risk factor of NASH overlapping with AIH in the present cohort. Our findings will facilitate development of a new noninvasive FCM method for indicating risk factors of NASH, including autoimmunity.CONCLUSIONSThe decreased frequency of peripheral CD8+ PD1+ T cells is an independent risk factor of NASH overlapping with AIH in the present cohort. Our findings will facilitate development of a new noninvasive FCM method for indicating risk factors of NASH, including autoimmunity.
BackgroundNonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA) positivity and overlap of autoimmune hepatitis (AIH). Discriminating AIH-overlap NASH from NAFLD/NASH is required for proper treatment, and typically involves pathological diagnosis by invasive liver biopsy. Differential patterns of peripheral lymphocytes in NAFLD and AIH were assessed to noninvasively indicate risk factors of AIH-overlap NASH by flow cytometry (FCM).MethodsWe assessed the differential frequencies of peripheral lymphocytes in 115 patients: 70 NASH (ANA negative:positive:AIH-overlap = 36:20:14), 18 NAFL, and 27 AIH (acute:chronic = 12:15) patients diagnosed by FCM. We focused on the following populations of lymphocytes: T cells, B cells, natural killer (NK) cells, NKT cells, helper T cell (Th) subsets (Th1, Th2, and Th17), and regulatory T cells; we also examined programmed cell death (PD) 1 and cytotoxic T-lymphocyte antigen levels.ResultsSeveral significant differences in laboratory parameters and peripheral lymphocyte frequencies were found among the NAFLD and AIH subgroups. In univariate and multivariate analyses, hyaluronic acid level, liver stiffness, and the frequencies of Th17 and CD8+ PD1+ T cells were independent risk factors of NASH in NAFLD. Regarding overlap of AIH, only the frequency of CD8+ PD1+ T cells (odds ratio, 0.01; 95% CI 0.00–38.9, p = 0.004) was an independent risk factor in NASH and significantly decreased in AIH.ConclusionsThe decreased frequency of peripheral CD8+ PD1+ T cells is an independent risk factor of NASH overlapping with AIH in the present cohort. Our findings will facilitate development of a new noninvasive FCM method for indicating risk factors of NASH, including autoimmunity.
Background Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA) positivity and overlap of autoimmune hepatitis (AIH). Discriminating AIH-overlap NASH from NAFLD/NASH is required for proper treatment, and typically involves pathological diagnosis by invasive liver biopsy. Differential patterns of peripheral lymphocytes in NAFLD and AIH were assessed to noninvasively indicate risk factors of AIH-overlap NASH by flow cytometry (FCM). Methods We assessed the differential frequencies of peripheral lymphocytes in 115 patients: 70 NASH (ANA negative:positive:AIH-overlap = 36:20:14), 18 NAFL, and 27 AIH (acute:chronic = 12:15) patients diagnosed by FCM. We focused on the following populations of lymphocytes: T cells, B cells, natural killer (NK) cells, NKT cells, helper T cell (Th) subsets (Th1, Th2, and Th17), and regulatory T cells; we also examined programmed cell death (PD) 1 and cytotoxic T-lymphocyte antigen levels. Results Several significant differences in laboratory parameters and peripheral lymphocyte frequencies were found among the NAFLD and AIH subgroups. In univariate and multivariate analyses, hyaluronic acid level, liver stiffness, and the frequencies of Th17 and CD8 + PD1 + T cells were independent risk factors of NASH in NAFLD. Regarding overlap of AIH, only the frequency of CD8 + PD1 + T cells (odds ratio, 0.01; 95% CI 0.00–38.9, p  = 0.004) was an independent risk factor in NASH and significantly decreased in AIH. Conclusions The decreased frequency of peripheral CD8 + PD1 + T cells is an independent risk factor of NASH overlapping with AIH in the present cohort. Our findings will facilitate development of a new noninvasive FCM method for indicating risk factors of NASH, including autoimmunity.
Audience Academic
Author Ikeuchi, Kazuhiko
Tsutsumi, Takeya
Fujishiro, Mitsuhiro
Yotsuyanagi, Hiroshi
Koike, Kazuhiko
Kado, Akira
Moriya, Kyoji
Okushin, Kazuya
Author_xml – sequence: 1
  givenname: Akira
  surname: Kado
  fullname: Kado, Akira
  organization: Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Division for Health Service Promotion, The University of Tokyo
– sequence: 2
  givenname: Takeya
  orcidid: 0000-0003-0851-1887
  surname: Tsutsumi
  fullname: Tsutsumi, Takeya
  email: takeyatsutsumi@g.ecc.u-tokyo.ac.jp
  organization: Department of Infection Control and Prevention, Graduate School of Medicine, The University of Tokyo
– sequence: 3
  givenname: Hiroshi
  surname: Yotsuyanagi
  fullname: Yotsuyanagi, Hiroshi
  organization: Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo
– sequence: 4
  givenname: Kazuhiko
  surname: Ikeuchi
  fullname: Ikeuchi, Kazuhiko
  organization: Department of Infectious Diseases, Graduate School of Medicine, The University of Tokyo
– sequence: 5
  givenname: Kazuya
  surname: Okushin
  fullname: Okushin, Kazuya
  organization: Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Department of Infection Control and Prevention, Graduate School of Medicine, The University of Tokyo
– sequence: 6
  givenname: Kyoji
  surname: Moriya
  fullname: Moriya, Kyoji
  organization: Division for Health Service Promotion, The University of Tokyo
– sequence: 7
  givenname: Kazuhiko
  surname: Koike
  fullname: Koike, Kazuhiko
  organization: Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Department of Gastroenterology, Kanto Central Hospital
– sequence: 8
  givenname: Mitsuhiro
  surname: Fujishiro
  fullname: Fujishiro, Mitsuhiro
  organization: Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37707595$$D View this record in MEDLINE/PubMed
BookMark eNp9ks9u3CAQxlGVqtmkfYEeKqReenEKBox9jKL0jxS1l_aMWDzeJbXBBbzSPkjft7PdRGmjKkKANPy-D5iZM3ISYgBCXnN2wRnT7zNjSqiK1QInE221f0ZWXGJIdXV9Qlask7LiXMtTcpbzLWNcMNW-IKdCa6ZVp1bk15cYfNjZ7HdA7TynaN2Wlkh96L2zBWjy-QcdrCsxZRoHio-wo4vbOHpHcwFb4hZmW3zxeL6DNKKNDxtqlxL9NC0B6AOwthl6GgOdIfl5C8mOdNxP8za6PV6GWIEUXpLngx0zvLrbz8n3D9ffrj5VN18_fr66vKmc0k2pmsGKttOuHiyvbasFt7yXjEne8962ci3WAjo1NFxIxxzTaycbrYBLXIa-Fefk3dEX__1zgVzM5LODcbQB4pJN3Tay7RrFa0TfPkJv45IwFQeq46qtFfuL2tgRjA9DLMm6g6m51FoozmrdIXXxHwpHD5N3WOTBY_wfwZu7y5f1BL2Zk59s2pv7OiLQHgGXYs4JBuN8wZTHgM5-NJyZQ8uYY8sYfKn50zJmj9L6kfTe_UmROIoywmED6SEbT6h-A06u1gc
CitedBy_id crossref_primary_10_1038_s41598_024_76084_8
crossref_primary_10_1007_s42452_024_06124_5
crossref_primary_10_1016_j_ijbiomac_2024_135256
Cites_doi 10.1155/2013/607073
10.1016/S0168-8278(99)80297-9
10.1002/hep.21541
10.1111/j.1572-0241.2004.30444.x
10.1111/hepr.12210
10.1007/s00535-015-1129-1
10.1016/j.ebiom.2021.103768
10.1016/S0016-5085(99)70506-8
10.1371/journal.pone.0239481
10.1016/j.jsbmb.2015.07.020
10.1111/j.1872-034X.2007.00150.x
10.2169/internalmedicine.8887-17
10.1016/j.jhep.2015.06.030
10.3389/fimmu.2020.575572
10.1016/j.cyto.2014.09.011
10.1515/cclm-2013-0926
10.1038/nrgastro.2013.41
10.14309/ajg.0000000000000676
10.1002/cyto.a.24272
10.3389/fimmu.2019.01255
10.1089/vim.2018.0035
10.1002/hep.28776
10.1002/hep.25762
10.1055/s-0040-1713006
10.1073/pnas.1608873113
10.1159/000440747
10.1038/s41575-019-0210-2
10.4049/jimmunol.1501175
10.14715/cmb/2018.64.5.19
10.1016/j.jhep.2017.09.021
10.1038/s41467-021-24734-0
10.1016/j.immuni.2012.06.016
10.1371/journal.pone.0143380
10.1007/s00535-019-01565-x
10.3389/fphar.2019.00244
10.1007/s12016-013-8383-x
10.1002/cyto.10092
10.1016/j.ejim.2020.02.001
10.1007/s00535-022-01932-1
10.1038/nature14468
10.1016/j.jhep.2020.05.053
10.1038/nrc3239
10.1111/hepr.13683
10.1177/0961203315604910
10.1038/nrgastro.2015.200
10.1080/00365521.2016.1233576
10.1016/j.jhep.2019.08.024
10.1007/s00535-020-01679-7
10.1111/hepr.13764
10.1146/annurev-med-012017-043208
10.1053/j.gastro.2008.06.042
10.3389/fimmu.2019.02172
10.4049/jimmunol.1900124
10.1016/j.cellimm.2017.12.008
10.1038/s41577-021-00639-3
10.1002/cpt.2423
10.1007/s00535-021-01796-x
10.3389/fimmu.2019.01065
10.1073/pnas.97.3.1184
10.1002/hep.23599
10.3389/fimmu.2019.00082
10.1016/j.jhep.2012.02.029
10.1001/jamanetworkopen.2019.12565
10.1097/MCG.0000000000001817
10.1007/s00535-016-1267-0
ContentType Journal Article
Copyright The Author(s) 2023
2023. The Author(s).
COPYRIGHT 2023 Springer
The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2023
– notice: 2023. The Author(s).
– notice: COPYRIGHT 2023 Springer
– notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7T5
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
FYUFA
GHDGH
H94
K9-
K9.
KB0
M0R
M0S
M1P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/s00535-023-02038-y
DatabaseName SpringerOpen Free (Free internet resource, activated by CARLI)
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Immunology Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Consumer Health Database
ProQuest Health & Medical Collection
Medical Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE


MEDLINE - Academic
ProQuest One Academic Middle East (New)

Database_xml – sequence: 1
  dbid: C6C
  name: SpringerOpen Free (Free internet resource, activated by CARLI)
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1435-5922
EndPage 1251
ExternalDocumentID A773510279
37707595
10_1007_s00535_023_02038_y
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Miyakawa Memorial Research Foundation
  funderid: http://dx.doi.org/10.13039/501100007669
– fundername: The University of Tokyo
– fundername: Japan Agency for Medical Research and Development
  grantid: JP22fk0210090
  funderid: http://dx.doi.org/10.13039/100009619
– fundername: Japan Agency for Medical Research and Development
  grantid: JP22fk0210090
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.55
.86
.GJ
.VR
06C
06D
0R~
0VY
199
1N0
2.D
203
28-
29K
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3O-
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5VS
67Z
6NX
78A
7RV
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACUDM
ACZOJ
ADBBV
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
AXYYD
AZFZN
AZQEC
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BKNYI
BPHCQ
BSONS
BVXVI
C6C
CAG
CCPQU
COF
CS3
CSCUP
D-I
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IAO
IHE
IHR
IJ-
IKXTQ
IMOTQ
INH
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
K9-
KDC
KOV
KOW
KPH
LAS
LLZTM
M0R
M1P
M4Y
MA-
N2Q
N9A
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P2P
P9S
PCD
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
WOW
X7M
YLTOR
Z45
Z7U
Z7W
Z82
Z83
Z87
Z8O
Z8Q
Z8V
Z8W
Z91
ZMTXR
ZOVNA
~EX
~KM
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
AEIIB
PMFND
7T5
7XB
8FK
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
PUEGO
7X8
ID FETCH-LOGICAL-c576t-6fa3897c2fa12a8731a1d40041d1da84b3b3e95f6134c0c07bc4675e1475efd83
IEDL.DBID U2A
ISSN 0944-1174
1435-5922
IngestDate Tue Aug 05 10:31:52 EDT 2025
Sat Aug 23 14:30:24 EDT 2025
Tue Jun 17 22:03:09 EDT 2025
Tue Jun 10 21:06:42 EDT 2025
Mon Jul 21 06:04:53 EDT 2025
Tue Jul 01 04:34:20 EDT 2025
Thu Apr 24 22:54:58 EDT 2025
Fri Feb 21 02:43:59 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Peripheral blood mononuclear cells
Flow cytometry
Peripheral lymphocyte frequency
Nonalcoholic steatohepatitis
Autoimmune hepatitis
Language English
License 2023. The Author(s).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c576t-6fa3897c2fa12a8731a1d40041d1da84b3b3e95f6134c0c07bc4675e1475efd83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-0851-1887
OpenAccessLink https://link.springer.com/10.1007/s00535-023-02038-y
PMID 37707595
PQID 2891582502
PQPubID 33411
PageCount 15
ParticipantIDs proquest_miscellaneous_2864896512
proquest_journals_2891582502
gale_infotracmisc_A773510279
gale_infotracacademiconefile_A773510279
pubmed_primary_37707595
crossref_citationtrail_10_1007_s00535_023_02038_y
crossref_primary_10_1007_s00535_023_02038_y
springer_journals_10_1007_s00535_023_02038_y
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-12-01
PublicationDateYYYYMMDD 2023-12-01
PublicationDate_xml – month: 12
  year: 2023
  text: 2023-12-01
  day: 01
PublicationDecade 2020
PublicationPlace Singapore
PublicationPlace_xml – name: Singapore
– name: Japan
– name: Tokyo
PublicationTitle Journal of gastroenterology
PublicationTitleAbbrev J Gastroenterol
PublicationTitleAlternate J Gastroenterol
PublicationYear 2023
Publisher Springer Nature Singapore
Springer
Springer Nature B.V
Publisher_xml – name: Springer Nature Singapore
– name: Springer
– name: Springer Nature B.V
References Younes, Govaere, Petta (CR11) 2020; 115
Tokushige, Hyogo, Nakajima (CR2) 2016; 51
Chalasani, Younossi, Lavine (CR8) 2012; 55
Raphael, Nalawade, Eagar (CR37) 2015; 74
Ugarte-Gil, Sánchez-Zúñiga, Gamboa-Cárdenas (CR16) 2016; 25
Van Herck, Weyler, Kwanten (CR57) 2019; 10
Shen, Xu, Yu (CR45) 2018; 31
Penna, Pilli, Zerbini (CR46) 2007; 45
Abe, Fujita, Hayashi (CR24) 2020; 15
Kado, Tsutsumi, Enooku (CR12) 2019; 54
Dalekos, Gatselis, Zachou (CR65) 2020; 75
Hu, Zhao, Wang (CR27) 2014; 52
Matteoni, Younossi, Gramlich (CR28) 1999; 116
Huby, Gautier (CR10) 2022; 22
Stiglund, Strand, Cornillet (CR42) 2019; 10
Suarez-Fueyo, Tsokos, Kwok (CR54) 2019; 10
Seike, Mizukoshi, Yamada (CR17) 2020; 55
Abe, Hiasa, Onji (CR58) 2013; 2013
McKinney, Lee, Jayne (CR49) 2015; 523
Anstee, Targher, Day (CR1) 2013; 10
Cueto-Sanchez, Niu, Del Campo-Herrera (CR20) 2021; 110
(CR25) 2015; 63
Huang, Wang, He (CR36) 2018; 64
Woods, Hazlehurst, Tomlinson (CR6) 2015; 154
Vonghia, Magrone, Verrijken (CR22) 2015; 10
Koda, Teratani, Chu (CR51) 2021; 12
Tanaka, Notohara (CR32) 2021; 51
Komura, Ohta, Seike (CR7) 2018; 57
Tiniakos, Brain, Bury (CR31) 2015; 33
Wang, Luo, Wan (CR44) 2020; 72
Boes, Schmidt, Linkemann (CR52) 2000; 97
Renand, Cervera-Marzal, Gil (CR19) 2020; 73
Hashimoto, Kamphorst, Im (CR43) 2018; 69
Zhang, Chikuma, Hori (CR40) 2016; 113
Sebode, Wigger, Filpe (CR63) 2019; 10
Xiao, Ai, Yan (CR60) 2018; 327
Lin, Fan (CR18) 2022; 75
Lynch, Nowak, Varghese (CR61) 2012; 37
Sutti, Albano (CR9) 2020; 17
Peiseler, Sebode, Franke (CR21) 2012; 57
Yoshioka, Taniai, Hashimoto (CR53) 2014; 44
Tamaki, Kurosaki, Huang (CR14) 2022; 52
Bergeron, Nicholson, Phaneuf (CR35) 2002; 50
Kamada, Nakamura, Isobe (CR15) 2023; 58
Aarslev, Dige, Greisen (CR48) 2017; 52
Niwa, Sasaki, Haratake (CR4) 2007; 37
Alvarez, Berg, Bianchi (CR30) 1999; 31
CR29
Wang, Zhong, Zhang (CR38) 2021; 99
Bovensiepen, Schakat, Sebode (CR64) 2019; 203
Lonardo, Nascimbeni, Mantovani (CR3) 2018; 68
Tokushige, Ikejima, Ono (CR50) 2021; 56
Tsuneyama, Baba, Kikuchi (CR33) 2013; 45
CR26
Adams, Chan (CR55) 2020; 40
Syn, Oo, Pereira (CR62) 2010; 51
CR23
Kido, Watanabe, Okazaki (CR47) 2008; 135
Adams, Lindor, Angulo (CR5) 2004; 99
Pardoll (CR41) 2012; 12
Ajmera, Perito, Bass (CR13) 2017; 65
Heymann, Tacke (CR59) 2016; 13
Hansel, Erschfeld, Baues (CR34) 2019; 10
Wang, Feng, Yan (CR39) 2020; 11
Rau, Schilling, Meertens (CR56) 2016; 196
B Zhang (2038_CR40) 2016; 113
T Komura (2038_CR7) 2018; 57
Y Kamada (2038_CR15) 2023; 58
M Abe (2038_CR58) 2013; 2013
A Kado (2038_CR12) 2019; 54
A Tanaka (2038_CR32) 2021; 51
H Niwa (2038_CR4) 2007; 37
K Aarslev (2038_CR48) 2017; 52
CA Matteoni (2038_CR28) 1999; 116
WK Syn (2038_CR62) 2010; 51
F Heymann (2038_CR59) 2016; 13
MF Ugarte-Gil (2038_CR16) 2016; 25
K Tsuneyama (2038_CR33) 2013; 45
T Huby (2038_CR10) 2022; 22
H Wang (2038_CR39) 2020; 11
K Abe (2038_CR24) 2020; 15
M Rau (2038_CR56) 2016; 196
M Peiseler (2038_CR21) 2012; 57
H Wang (2038_CR44) 2020; 72
F Xiao (2038_CR60) 2018; 327
LA Adams (2038_CR55) 2020; 40
S Sutti (2038_CR9) 2020; 17
M Bergeron (2038_CR35) 2002; 50
DM Pardoll (2038_CR41) 2012; 12
QM Anstee (2038_CR1) 2013; 10
T Seike (2038_CR17) 2020; 55
L Vonghia (2038_CR22) 2015; 10
XH Shen (2038_CR45) 2018; 31
LA Adams (2038_CR5) 2004; 99
K Tokushige (2038_CR50) 2021; 56
C Hansel (2038_CR34) 2019; 10
GN Dalekos (2038_CR65) 2020; 75
European Association for the Study of the Liver (2038_CR25) 2015; 63
F Alvarez (2038_CR30) 1999; 31
SZ Lin (2038_CR18) 2022; 75
S Hu (2038_CR27) 2014; 52
2038_CR29
Y Yoshioka (2038_CR53) 2014; 44
2038_CR23
2038_CR26
N Tamaki (2038_CR14) 2022; 52
M Boes (2038_CR52) 2000; 97
A Penna (2038_CR46) 2007; 45
CS Bovensiepen (2038_CR64) 2019; 203
A Lonardo (2038_CR3) 2018; 68
CP Woods (2038_CR6) 2015; 154
M Sebode (2038_CR63) 2019; 10
SR Wang (2038_CR38) 2021; 99
M Hashimoto (2038_CR43) 2018; 69
DG Tiniakos (2038_CR31) 2015; 33
EF McKinney (2038_CR49) 2015; 523
Y Koda (2038_CR51) 2021; 12
N Chalasani (2038_CR8) 2012; 55
M Kido (2038_CR47) 2008; 135
V Ajmera (2038_CR13) 2017; 65
MA Van Herck (2038_CR57) 2019; 10
N Stiglund (2038_CR42) 2019; 10
A Suarez-Fueyo (2038_CR54) 2019; 10
L Lynch (2038_CR61) 2012; 37
LQ Huang (2038_CR36) 2018; 64
A Renand (2038_CR19) 2020; 73
R Younes (2038_CR11) 2020; 115
A Cueto-Sanchez (2038_CR20) 2021; 110
I Raphael (2038_CR37) 2015; 74
K Tokushige (2038_CR2) 2016; 51
References_xml – volume: 2013
  year: 2013
  ident: CR58
  article-title: T helper 17 cells in autoimmune liver diseases
  publication-title: Clin Dev Immunol
  doi: 10.1155/2013/607073
– volume: 31
  start-page: 929
  year: 1999
  end-page: 938
  ident: CR30
  article-title: International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis
  publication-title: J Hepatol
  doi: 10.1016/S0168-8278(99)80297-9
– volume: 45
  start-page: 588
  year: 2007
  end-page: 601
  ident: CR46
  article-title: Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection
  publication-title: Hepatology
  doi: 10.1002/hep.21541
– volume: 99
  start-page: 1316
  year: 2004
  end-page: 1320
  ident: CR5
  article-title: The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2004.30444.x
– volume: 44
  start-page: 947
  year: 2014
  end-page: 955
  ident: CR53
  article-title: Clinical profile of primary biliary cirrhosis with features of autoimmune hepatitis: Importance of corticosteroid therapy
  publication-title: Hepatol Res
  doi: 10.1111/hepr.12210
– volume: 51
  start-page: 586
  year: 2016
  end-page: 596
  ident: CR2
  article-title: Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-015-1129-1
– volume: 75
  year: 2022
  ident: CR18
  article-title: Peripheral immune cells in NAFLD patients: a spyhole to disease progression
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2021.103768
– volume: 116
  start-page: 1413
  year: 1999
  end-page: 1419
  ident: CR28
  article-title: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(99)70506-8
– volume: 15
  year: 2020
  ident: CR24
  article-title: Association of serum 25-hydroxyvitamin D levels with severe necroinflammatory activity and inflammatory cytokine production in type I autoimmune hepatitis
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0239481
– volume: 154
  start-page: 94
  year: 2015
  end-page: 103
  ident: CR6
  article-title: Glucocorticoids and non-alcoholic fatty liver disease
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/j.jsbmb.2015.07.020
– volume: 37
  start-page: 923
  year: 2007
  end-page: 931
  ident: CR4
  article-title: Clinicopathological significance of antinuclear antibodies in non-alcoholic steatohepatitis
  publication-title: Hepatol Res
  doi: 10.1111/j.1872-034X.2007.00150.x
– ident: CR29
– volume: 57
  start-page: 807
  year: 2018
  end-page: 812
  ident: CR7
  article-title: The efficacy of corticosteroid therapy in a patient with non-alcoholic steatohepatitis overlapping autoimmune hepatitis
  publication-title: Intern Med
  doi: 10.2169/internalmedicine.8887-17
– volume: 63
  start-page: 971
  year: 2015
  end-page: 1004
  ident: CR25
  article-title: EASL clinical practice guidelines: autoimmune hepatitis
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2015.06.030
– volume: 11
  year: 2020
  ident: CR39
  article-title: Regulatory T cells in autoimmune hepatitis: Unveiling their roles in mouse models and patients
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.575572
– volume: 74
  start-page: 5
  year: 2015
  end-page: 17
  ident: CR37
  article-title: T cell subsets and their signature cytokines in autoimmune and inflammatory diseases
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2014.09.011
– volume: 52
  start-page: 1533
  year: 2014
  end-page: 1542
  ident: CR27
  article-title: The accuracy of the anti-mitochondrial antibody and the M2 subtype test for diagnosis of primary biliary cirrhosis: A meta-analysis
  publication-title: Clin Chem Lab Med
  doi: 10.1515/cclm-2013-0926
– volume: 10
  start-page: 330
  year: 2013
  end-page: 344
  ident: CR1
  article-title: Progression of NAFLD to diabetes mellitus, cardiovascular disease, or cirrhosis
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2013.41
– volume: 115
  start-page: 1289
  year: 2020
  end-page: 1292
  ident: CR11
  article-title: Presence of serum antinuclear antibodies does not impact long-term outcomes in nonalcoholic fatty liver disease
  publication-title: Am J Gastroenterol
  doi: 10.14309/ajg.0000000000000676
– volume: 99
  start-page: 273
  year: 2021
  end-page: 277
  ident: CR38
  article-title: OMIP 071: A 31-parameter flow cytometry panel for in-depth immunophenotyping of human T-cell subsets using surface markers
  publication-title: Cytometry A
  doi: 10.1002/cyto.a.24272
– volume: 10
  start-page: 1255
  year: 2019
  ident: CR42
  article-title: Retained NK cell phenotype and functionality in non-alcoholic fatty liver disease
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.01255
– volume: 31
  start-page: 548
  year: 2018
  end-page: 558
  ident: CR45
  article-title: Discrepant clinical significance of CD28+CD8- and CD4+CD25high regulatory T cells during the progression of hepatitis B virus infection
  publication-title: Viral Immunol
  doi: 10.1089/vim.2018.0035
– volume: 65
  start-page: 65
  year: 2017
  end-page: 77
  ident: CR13
  article-title: NASH clinical research network. novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease
  publication-title: Hepatology
  doi: 10.1002/hep.28776
– volume: 55
  start-page: 2005
  year: 2012
  end-page: 2023
  ident: CR8
  article-title: The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association
  publication-title: Hepatology
  doi: 10.1002/hep.25762
– volume: 40
  start-page: 331
  year: 2020
  end-page: 338
  ident: CR55
  article-title: Noninvasive tests in the assessment of NASH and NAFLD Fibrosis: Now and into the future
  publication-title: Semin Liver Dis
  doi: 10.1055/s-0040-1713006
– volume: 113
  start-page: 8490
  year: 2016
  end-page: 8495
  ident: CR40
  article-title: Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1608873113
– volume: 33
  start-page: 53
  year: 2015
  end-page: 64
  ident: CR31
  article-title: Role of histopathology in autoimmune hepatitis
  publication-title: Dig Dis
  doi: 10.1159/000440747
– volume: 17
  start-page: 81
  year: 2020
  end-page: 92
  ident: CR9
  article-title: Adaptive immunity: an emerging player in the progression of NAFLD
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/s41575-019-0210-2
– volume: 196
  start-page: 97
  year: 2016
  end-page: 105
  ident: CR56
  article-title: Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17/resting regulatory T cell ratio in peripheral blood and in the liver
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1501175
– ident: CR26
– volume: 64
  start-page: 113
  issue: 5
  year: 2018
  end-page: 117
  ident: CR36
  article-title: Analysis of peripheral blood T-cell subsets and regulatory T-cells in multiple myeloma patients
  publication-title: Cell Mol Biol
  doi: 10.14715/cmb/2018.64.5.19
– volume: 68
  start-page: 335
  year: 2018
  end-page: 352
  ident: CR3
  article-title: Hypertension, diabetes, atherosclerosis, and NASH: Cause or consequence?
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2017.09.021
– volume: 12
  start-page: 4474
  year: 2021
  ident: CR51
  article-title: CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells
  publication-title: Nat Commun
  doi: 10.1038/s41467-021-24734-0
– volume: 37
  start-page: 574
  year: 2012
  end-page: 587
  ident: CR61
  article-title: Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production
  publication-title: Immunity
  doi: 10.1016/j.immuni.2012.06.016
– volume: 10
  year: 2015
  ident: CR22
  article-title: Peripheral and hepatic vein cytokine levels in correlation with non-alcoholic fatty liver disease (NAFLD)-related metabolic, histological, and haemodynamic features
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0143380
– volume: 54
  start-page: 730
  year: 2019
  end-page: 741
  ident: CR12
  article-title: Noninvasive diagnostic criteria for nonalcoholic steatohepatitis based on gene expression levels in peripheral blood mononuclear cells
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-019-01565-x
– volume: 10
  start-page: 244
  year: 2019
  ident: CR34
  article-title: The inhibitory cell receptors PD1 and 2B4 are differentially regulated on CD4 and CD8 T cells in a mouse model of non-alcoholic steatohepatitis
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2019.00244
– volume: 45
  start-page: 143
  year: 2013
  end-page: 148
  ident: CR33
  article-title: Autoimmune features in metabolic liver disease: a single-center experience and review of the literature
  publication-title: Clin Rev Allergy Immunol
  doi: 10.1007/s12016-013-8383-x
– volume: 50
  start-page: 53
  year: 2002
  end-page: 61
  ident: CR35
  article-title: Selection of lymphocyte gating protocol has an impact on the level of reliability of T-cell subsets in aging specimens
  publication-title: Cytometry
  doi: 10.1002/cyto.10092
– volume: 75
  start-page: 1
  year: 2020
  end-page: 9
  ident: CR65
  article-title: NAFLD and autoimmune hepatitis: do not judge a book by its cover
  publication-title: Eur J Intern Med
  doi: 10.1016/j.ejim.2020.02.001
– volume: 58
  start-page: 79
  year: 2023
  end-page: 97
  ident: CR15
  article-title: JANIT forum SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT forum
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-022-01932-1
– volume: 523
  start-page: 612
  year: 2015
  end-page: 616
  ident: CR49
  article-title: T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
  publication-title: Nature
  doi: 10.1038/nature14468
– volume: 73
  start-page: 1379
  year: 2020
  end-page: 1390
  ident: CR19
  article-title: Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitis
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2020.05.053
– volume: 12
  start-page: 252
  year: 2012
  end-page: 264
  ident: CR41
  article-title: The blockade of immune checkpoints in cancer immunotherapy
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3239
– volume: 51
  start-page: 850
  year: 2021
  end-page: 859
  ident: CR32
  article-title: Immunoglobulin G4 (IgG4)-related autoimmune hepatitis and IgG4-hepatopathy: a histopathological and clinical perspective
  publication-title: Hepatol Res
  doi: 10.1111/hepr.13683
– volume: 25
  start-page: 233
  year: 2016
  end-page: 240
  ident: CR16
  article-title: Circulating CD4 CD28null and extra-thymic CD4 CD8 double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients
  publication-title: Lupus
  doi: 10.1177/0961203315604910
– volume: 13
  start-page: 88
  year: 2016
  end-page: 110
  ident: CR59
  article-title: Immunology in the liver—from homeostasis to disease
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2015.200
– ident: CR23
– volume: 52
  start-page: 93
  year: 2017
  end-page: 99
  ident: CR48
  article-title: Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis
  publication-title: Scand J Gastroenterol
  doi: 10.1080/00365521.2016.1233576
– volume: 72
  start-page: 45
  year: 2020
  end-page: 56
  ident: CR44
  article-title: TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2019.08.024
– volume: 55
  start-page: 701
  year: 2020
  end-page: 711
  ident: CR17
  article-title: Fatty acid-driven modifications in T-cell profiles in non-alcoholic fatty liver disease patients
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-020-01679-7
– volume: 52
  start-page: 497
  year: 2022
  end-page: 507
  ident: CR14
  article-title: Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease
  publication-title: Hepatol Res
  doi: 10.1111/hepr.13764
– volume: 69
  start-page: 301
  year: 2018
  end-page: 318
  ident: CR43
  article-title: CD8 T cell exhaustion in chronic infection and cancer: opportunities for interventions
  publication-title: Annu Rev Med
  doi: 10.1146/annurev-med-012017-043208
– volume: 135
  start-page: 1333
  year: 2008
  end-page: 1343
  ident: CR47
  article-title: Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2008.06.042
– volume: 10
  start-page: 2172
  year: 2019
  ident: CR54
  article-title: Hyaluronic acid synthesis contributes to tissue damage in systemic lupus erythematosus
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.02172
– volume: 203
  start-page: 3148
  year: 2019
  end-page: 3156
  ident: CR64
  article-title: TNF-Producing Th1 cells are selectively expanded in liver infiltrates of patients with autoimmune hepatitis
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1900124
– volume: 327
  start-page: 13
  year: 2018
  end-page: 20
  ident: CR60
  article-title: Intrahepatic recruitment of cytotoxic NK cells contributes to autoimmune hepatitis progression
  publication-title: Cell Immunol
  doi: 10.1016/j.cellimm.2017.12.008
– volume: 22
  start-page: 429
  year: 2022
  end-page: 443
  ident: CR10
  article-title: Immune cell-mediated features of non-alcoholic steatohepatitis
  publication-title: Nat Rev Immunol
  doi: 10.1038/s41577-021-00639-3
– volume: 110
  start-page: 1604
  year: 2021
  end-page: 1612
  ident: CR20
  article-title: Lymphocyte profile and immune checkpoint expression in drug-induced liver injury: An immunophenotyping study
  publication-title: Clin Pharmacol Ther
  doi: 10.1002/cpt.2423
– volume: 56
  start-page: 951
  year: 2021
  end-page: 963
  ident: CR50
  article-title: Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-021-01796-x
– volume: 10
  start-page: 1065
  year: 2019
  ident: CR63
  article-title: Inflammatory phenotype of intrahepatic sulfatide-reactive type II NKT cells in humans with autoimmune hepatitis
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.01065
– volume: 97
  start-page: 1184
  year: 2000
  end-page: 1189
  ident: CR52
  article-title: Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.97.3.1184
– volume: 51
  start-page: 1998
  year: 2010
  end-page: 2007
  ident: CR62
  article-title: Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease
  publication-title: Hepatology
  doi: 10.1002/hep.23599
– volume: 10
  start-page: 82
  year: 2019
  ident: CR57
  article-title: The differential roles of T cells in non-alcoholic fatty liver disease and obesity
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.00082
– volume: 57
  start-page: 125
  year: 2012
  end-page: 132
  ident: CR21
  article-title: FOXP3 regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2012.02.029
– volume: 55
  start-page: 2005
  year: 2012
  ident: 2038_CR8
  publication-title: Hepatology
  doi: 10.1002/hep.25762
– volume: 73
  start-page: 1379
  year: 2020
  ident: 2038_CR19
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2020.05.053
– volume: 22
  start-page: 429
  year: 2022
  ident: 2038_CR10
  publication-title: Nat Rev Immunol
  doi: 10.1038/s41577-021-00639-3
– volume: 31
  start-page: 929
  year: 1999
  ident: 2038_CR30
  publication-title: J Hepatol
  doi: 10.1016/S0168-8278(99)80297-9
– volume: 37
  start-page: 574
  year: 2012
  ident: 2038_CR61
  publication-title: Immunity
  doi: 10.1016/j.immuni.2012.06.016
– volume: 55
  start-page: 701
  year: 2020
  ident: 2038_CR17
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-020-01679-7
– volume: 10
  start-page: 1065
  year: 2019
  ident: 2038_CR63
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.01065
– volume: 12
  start-page: 252
  year: 2012
  ident: 2038_CR41
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3239
– volume: 50
  start-page: 53
  year: 2002
  ident: 2038_CR35
  publication-title: Cytometry
  doi: 10.1002/cyto.10092
– volume: 99
  start-page: 1316
  year: 2004
  ident: 2038_CR5
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2004.30444.x
– volume: 203
  start-page: 3148
  year: 2019
  ident: 2038_CR64
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1900124
– volume: 31
  start-page: 548
  year: 2018
  ident: 2038_CR45
  publication-title: Viral Immunol
  doi: 10.1089/vim.2018.0035
– volume: 523
  start-page: 612
  year: 2015
  ident: 2038_CR49
  publication-title: Nature
  doi: 10.1038/nature14468
– volume: 12
  start-page: 4474
  year: 2021
  ident: 2038_CR51
  publication-title: Nat Commun
  doi: 10.1038/s41467-021-24734-0
– volume: 52
  start-page: 1533
  year: 2014
  ident: 2038_CR27
  publication-title: Clin Chem Lab Med
  doi: 10.1515/cclm-2013-0926
– volume: 44
  start-page: 947
  year: 2014
  ident: 2038_CR53
  publication-title: Hepatol Res
  doi: 10.1111/hepr.12210
– volume: 97
  start-page: 1184
  year: 2000
  ident: 2038_CR52
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.97.3.1184
– volume: 54
  start-page: 730
  year: 2019
  ident: 2038_CR12
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-019-01565-x
– volume: 68
  start-page: 335
  year: 2018
  ident: 2038_CR3
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2017.09.021
– volume: 2013
  year: 2013
  ident: 2038_CR58
  publication-title: Clin Dev Immunol
  doi: 10.1155/2013/607073
– volume: 57
  start-page: 807
  year: 2018
  ident: 2038_CR7
  publication-title: Intern Med
  doi: 10.2169/internalmedicine.8887-17
– volume: 57
  start-page: 125
  year: 2012
  ident: 2038_CR21
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2012.02.029
– ident: 2038_CR29
  doi: 10.1001/jamanetworkopen.2019.12565
– volume: 51
  start-page: 1998
  year: 2010
  ident: 2038_CR62
  publication-title: Hepatology
  doi: 10.1002/hep.23599
– volume: 52
  start-page: 497
  year: 2022
  ident: 2038_CR14
  publication-title: Hepatol Res
  doi: 10.1111/hepr.13764
– volume: 58
  start-page: 79
  year: 2023
  ident: 2038_CR15
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-022-01932-1
– volume: 110
  start-page: 1604
  year: 2021
  ident: 2038_CR20
  publication-title: Clin Pharmacol Ther
  doi: 10.1002/cpt.2423
– volume: 17
  start-page: 81
  year: 2020
  ident: 2038_CR9
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/s41575-019-0210-2
– volume: 10
  start-page: 244
  year: 2019
  ident: 2038_CR34
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2019.00244
– volume: 10
  start-page: 1255
  year: 2019
  ident: 2038_CR42
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.01255
– volume: 25
  start-page: 233
  year: 2016
  ident: 2038_CR16
  publication-title: Lupus
  doi: 10.1177/0961203315604910
– volume: 51
  start-page: 586
  year: 2016
  ident: 2038_CR2
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-015-1129-1
– volume: 75
  start-page: 1
  year: 2020
  ident: 2038_CR65
  publication-title: Eur J Intern Med
  doi: 10.1016/j.ejim.2020.02.001
– volume: 51
  start-page: 850
  year: 2021
  ident: 2038_CR32
  publication-title: Hepatol Res
  doi: 10.1111/hepr.13683
– volume: 154
  start-page: 94
  year: 2015
  ident: 2038_CR6
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/j.jsbmb.2015.07.020
– volume: 56
  start-page: 951
  year: 2021
  ident: 2038_CR50
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-021-01796-x
– volume: 327
  start-page: 13
  year: 2018
  ident: 2038_CR60
  publication-title: Cell Immunol
  doi: 10.1016/j.cellimm.2017.12.008
– volume: 115
  start-page: 1289
  year: 2020
  ident: 2038_CR11
  publication-title: Am J Gastroenterol
  doi: 10.14309/ajg.0000000000000676
– volume: 10
  start-page: 330
  year: 2013
  ident: 2038_CR1
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2013.41
– volume: 196
  start-page: 97
  year: 2016
  ident: 2038_CR56
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1501175
– volume: 11
  year: 2020
  ident: 2038_CR39
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.575572
– ident: 2038_CR23
  doi: 10.1097/MCG.0000000000001817
– volume: 45
  start-page: 588
  year: 2007
  ident: 2038_CR46
  publication-title: Hepatology
  doi: 10.1002/hep.21541
– volume: 116
  start-page: 1413
  year: 1999
  ident: 2038_CR28
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(99)70506-8
– volume: 10
  start-page: 82
  year: 2019
  ident: 2038_CR57
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.00082
– volume: 52
  start-page: 93
  year: 2017
  ident: 2038_CR48
  publication-title: Scand J Gastroenterol
  doi: 10.1080/00365521.2016.1233576
– volume: 72
  start-page: 45
  year: 2020
  ident: 2038_CR44
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2019.08.024
– volume: 64
  start-page: 113
  issue: 5
  year: 2018
  ident: 2038_CR36
  publication-title: Cell Mol Biol
  doi: 10.14715/cmb/2018.64.5.19
– volume: 65
  start-page: 65
  year: 2017
  ident: 2038_CR13
  publication-title: Hepatology
  doi: 10.1002/hep.28776
– volume: 75
  year: 2022
  ident: 2038_CR18
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2021.103768
– volume: 74
  start-page: 5
  year: 2015
  ident: 2038_CR37
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2014.09.011
– volume: 63
  start-page: 971
  year: 2015
  ident: 2038_CR25
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2015.06.030
– volume: 45
  start-page: 143
  year: 2013
  ident: 2038_CR33
  publication-title: Clin Rev Allergy Immunol
  doi: 10.1007/s12016-013-8383-x
– volume: 13
  start-page: 88
  year: 2016
  ident: 2038_CR59
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2015.200
– volume: 135
  start-page: 1333
  year: 2008
  ident: 2038_CR47
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2008.06.042
– volume: 10
  start-page: 2172
  year: 2019
  ident: 2038_CR54
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.02172
– volume: 37
  start-page: 923
  year: 2007
  ident: 2038_CR4
  publication-title: Hepatol Res
  doi: 10.1111/j.1872-034X.2007.00150.x
– volume: 33
  start-page: 53
  year: 2015
  ident: 2038_CR31
  publication-title: Dig Dis
  doi: 10.1159/000440747
– volume: 113
  start-page: 8490
  year: 2016
  ident: 2038_CR40
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1608873113
– volume: 40
  start-page: 331
  year: 2020
  ident: 2038_CR55
  publication-title: Semin Liver Dis
  doi: 10.1055/s-0040-1713006
– volume: 99
  start-page: 273
  year: 2021
  ident: 2038_CR38
  publication-title: Cytometry A
  doi: 10.1002/cyto.a.24272
– ident: 2038_CR26
  doi: 10.1007/s00535-016-1267-0
– volume: 69
  start-page: 301
  year: 2018
  ident: 2038_CR43
  publication-title: Annu Rev Med
  doi: 10.1146/annurev-med-012017-043208
– volume: 15
  year: 2020
  ident: 2038_CR24
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0239481
– volume: 10
  year: 2015
  ident: 2038_CR22
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0143380
SSID ssj0013058
Score 2.4212396
Snippet Background Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody...
Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA)...
Background Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody...
BackgroundNonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody...
SourceID proquest
gale
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1237
SubjectTerms Abdominal Surgery
Antinuclear antibodies
Apoptosis
Autoantibodies
Autoimmune diseases
Autoimmunity
B cells
Biliary Tract
Biopsy
CD8 antigen
Cell death
Chronic active hepatitis
Colorectal Surgery
Cytotoxicity
Fatty liver
Flow cytometry
Gastroenterology
Helper cells
Hepatitis
Hepatitis, Autoimmune - complications
Hepatology
Humans
Hyaluronic acid
Immunity
Immunoregulation
Liver
Liver diseases
Lymphocytes
Lymphocytes B
Lymphocytes T
Medical research
Medicine
Medicine & Public Health
Medicine, Experimental
Natural killer cells
Non-alcoholic Fatty Liver Disease - complications
Original Article―Liver
Pancreas
PD-1 protein
Risk Factors
Surgical Oncology
T cells
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB7aFEovpY-kcZoWFQo9pCKWLVv2qYTSEArJqYG9CUmWk4XF3iTewP6Q_t_MaOXdbqC5-CJZ1u48NTP6BuCrV8Ki4fM8NZaiVUZw49qai8rbwmZNUQW4pvOL8uxS_p4Ukxhwu4tllaNODIq66R3FyI_xYCAKPM6k2Y_5DaeuUZRdjS00nsMLgi6jki41UZssQhr6c-IJRnKBrne8NBOuzgVgE44Wi1MuruLLLcP0WD3_Y58eJUyDHTp9A6-jA8lOVhR_C8989w5enscU-Xv4e0EB1ntDZelsRAxnQ88oOU3lT4yqyVnss8P6lnXkjIdGuVPHiOhDf-2p0HqY4vg9BfwIxOGKmcXQT-k-iWebCWQGG9Z3jCCTA0bBjM2WyCO9W-LH5gG_s9uFy9Nff36e8dh7gTs8gQy8bA26MsplrRGZqVQujGhI3kUjGlNJm9vc10WL3oB0qUuVdahyCy8kPtqmyvdgB7fv94EZWxMqoTC4ksx9WbdtLZEP8grXtYVMQIx_vHYRmJz6Y8z0GlI5EEsjsXQgll4mcLR-Z76C5Xhy9jeipyaZxZWdiVcPcH-EfqVPlMpRN2WqTuBwaybKmtseHjlCR1m_0xvOTODLepjepPq1zvcLmlPKqi7Ru0rgw4qT1vvOlUK_rS4S-D6y1mbx__-og6f38hFeZcTdofLmEHaG24X_hP7TYD8HIXkAcckXtA
  priority: 102
  providerName: ProQuest
Title Noninvasive approach to indicate risk factors of nonalcoholic steatohepatitis overlapping autoimmune hepatitis based on peripheral lymphocyte pattern
URI https://link.springer.com/article/10.1007/s00535-023-02038-y
https://www.ncbi.nlm.nih.gov/pubmed/37707595
https://www.proquest.com/docview/2891582502
https://www.proquest.com/docview/2864896512
Volume 58
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED_WFsZeRrtPd23QYLCHTWD5S_ZjEpKVjYYxFsiejCTLXSDYZXUK-UP6_-5OsZ2mbIO9xA-SL0ruTnfS3f0O4J2VQqPhs9xXmm6rlODKlBkXqdWxDoo4dXBNl7PkYh59XsSLtijspst270KSbqfui90cFAlHG8MpepbyzQEcxXR2RymeB8Nd7MB3XTnx3BJxgQ53WyrzZxp75ujhpnzPKj0IkzrrMz2Gp63byIZbPp_AI1s9g8eXbWD8OdzN6Fr1VlEyOutwwllTMwpJU9IToxxy1nbXYXXJKnLBXXvcpWHE6qb-aSm9ulni-C1d8xF0wxVT66ZeUhWJZbsJZPwKVleMgJIdMsGKrTYoGbXZ4JddO9TO6gXMp5Pv4wvedlzgBs8dDU9KhQ6MNEGpRKBSGQolCtJyUYhCpZEOdWizuEQfIDK-8aU2uNHGVkT4URZp-BIOcfn2NTClM8IiFAopRaFNsrLMIuR-mCJdHUceiO6Pz00LR05dMVZ5D6TsmJUjs3LHrHzjwYf-nestGMc_Z78nfuakqUjZqLbgANdHmFf5UMoQd6RAZh6c7c1EDTP7w51E5K2G3-R4UBUxHq_9wIO3_TC9SVlrla3XNCeJ0ixBn8qDV1tJ6tcdSoneWhZ78LETrR3xv_-o0_-b_gaeBCTtLv_mDA6bX2t7jl5UowdwIBdyAEfD6Wg0o-enH18m-BxNZl-_4eg4GQ-cYv0GIZkbfw
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRcEG8CBYwE4gAWceK8DggVaLWl3RVCrdSbcRyHrrRKtjRblB_C3-A3MuNNdtlK9NZLLnYc7854Hp6ZbwBe2kTkqPgs93VOt1VacG3KjIvU5lEeFFHq4JpG43h4JL8cR8cb8KevhaG0yl4mOkFd1IbuyN-hYyAidGf84MPslFPXKIqu9i00Fmyxb9tf6LKdvd_7jPR9FQS7O4efhrzrKsAN2tYNj0uNSjoxQalFoNMkFFoUxMmiEIVOZR7moc2iEvWcNL7xk9ygMImskPgoizTEda_BpgzRlRnA5sed8ddvq7iF7zqCos8kuUBjvyvTccV6DkqFo47kFP1LebumCi8qhH804oUQrdN8u7fhVmeysu0Fj92BDVvdheujLih_D36P6Ur3XFMiPOsxyllTMwqHU8IVo_x11nX2YXXJKjL_XWveiWHEZk19Yim1u5ng-DldMRJsxA-m5009oQoWy1YTSPEWrK4YgTQ7VIQpm7bIlbVp8WMzhxha3YejK6HLAxjg9u0jYDrPCAdRaFxJhjbOyjKTyHlhiuvmkfRA9H-8Mh0UOnXkmKoliLMjlkJiKUcs1XrwZvnObAEEcuns10RPRVICVza6K3bA_RHeltpOkhClYZBkHmytzcTTbdaHe45QnXQ5U6uz4MGL5TC9SRlzla3nNCeWaRajPefBwwUnLfcdJglailnkwduetVaL__9HPb58L8_hxvBwdKAO9sb7T-BmQJzu8n62YND8nNunaL01-bPuyDD4ftWn9C-xPlVH
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB6VIlVcEP8EChgJxAGsxvlzckCooqxaSlccqLQ3YzsOrLRKFpotyoPwMjwdM95kl61Eb73kYsfx7nzjGXvG3wC8cFIYNHyOh9rQaZUWXNuq4CJ3JjVRmeaerulknB2eJh8n6WQL_gx3YSitclgT_UJdNpbOyPdwYyBS3M6E0V7Vp0V8Phi9m__gVEGKIq1DOY0lRI5d9wu3b2dvjw5Q1i-jaPThy_tD3lcY4Bb97JZnlUaDLW1UaRHpXMZCi5JQLUpR6jwxsYldkVZo8xIb2lAaiwtL6kSCj6rMYxz3GlyXcSpIx-REriMYoa8NirunhAt0-_sLO_7anidV4WgtOcUBc95tGMWLpuEf23ghWOtt4OgW3OydV7a_RNtt2HL1Hdg56cPzd-H3mA53zzWlxLOBrZy1DaPAOKVeMcpkZ32NH9ZUrKaNgC_SO7WMANc23x0lebdTbD-nw0YikPjG9KJtpnSXxbF1BzLBJWtqRnTNnh9hxmYd4rOxHX5s7rlD63tweiVSuQ_bOH33EJg2BTEiCo0jJbHLiqoqEsRgnOO4Jk0CEMMfr2xPik61OWZqRefshaVQWMoLS3UBvF69M19Sglza-xXJU9F6gSNb3V97wPkR85bal4SeMJJFALsbPVHP7WbzgAjVrzNnaq0VATxfNdOblDtXu2ZBfbIkLzL07AJ4sETSat6xlOgzFmkAbwZorQf__496dPlcnsEO6qb6dDQ-fgw3IgK6TwDahe3258I9QTeuNU-9vjD4etUK-hfhbVgX
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Noninvasive+approach+to+indicate+risk+factors+of+nonalcoholic+steatohepatitis+overlapping+autoimmune+hepatitis+based+on+peripheral+lymphocyte+pattern&rft.jtitle=Journal+of+gastroenterology&rft.au=Kado%2C+Akira&rft.au=Tsutsumi%2C+Takeya&rft.au=Yotsuyanagi%2C+Hiroshi&rft.au=Ikeuchi%2C+Kazuhiko&rft.date=2023-12-01&rft.issn=0944-1174&rft.eissn=1435-5922&rft.volume=58&rft.issue=12&rft.spage=1237&rft.epage=1251&rft_id=info:doi/10.1007%2Fs00535-023-02038-y&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00535_023_02038_y
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0944-1174&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0944-1174&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0944-1174&client=summon